Patient Guide: Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 197 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT01933932
Status: ACTIVE_NOT_RECRUITING
Condition: Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
Phase: PHASE3

Find a Study Location Near You

This study is available at 197 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Aurora, Colorado
  • Pembroke Pines, Florida
  • Atlanta, Georgia
  • • And 194 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily